Mold-Tek Packaging reported robust Q4 FY25 revenue growth driven by strong Food & FMCG performance and a significant ramp-up in its new Pharma division, which achieved breakeven. While full-year PAT saw a dip due to higher costs, the outlook for FY26 focuses on continued pharma expansion and a recovery in the paints segment.